Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif Friberg

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
European Heart Journal|July 19, 2006
Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)Leif Friberg, Niklas Hammar, Mattias Ringh, et al.
BMJ (Clinical Research Ed.)|June 2, 2012
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort studyLeif Friberg, Lina Benson, Mårten Rosenqvist, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 19, 2022
Prognostic implication of premature ventricular contractions in patients without structural heart diseaseRaffaele Scorza, Martin Jonsson, Leif Friberg, et al.
Clinical Cardiology|September 7, 2019
Risk of ischemic stroke and utility of CHA<sub>2</sub> DS<sub>2</sub> -VASc score in women and men with atrial fibrillationMaria Tomasdottir, Leif Friberg, Ziad Hijazi, et al.
European Journal of Preventive Cardiology|May 17, 2022
Prognostic impact of type 1 and type 2 diabetes mellitus in atrial fibrillation and the effect of severe hypoglycaemia: a nationwide cohort studyStelios Karayiannides, Anna Norhammar, Lena Landstedt-Hallin, et al.
JAMA|November 17, 2014
Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fractionLars H Lund, Lina Benson, Ulf Dahlström, et al.
Heart (British Cardiac Society)|January 27, 2018
Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failureGianluigi Savarese, Ulrik Sartipy, Leif Friberg, et al.
Stroke|July 19, 2014
High prevalence of atrial fibrillation among patients with ischemic strokeLeif Friberg, Mårten Rosenqvist, Arne Lindgren, et al.
Circulation|April 26, 2015
Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP StudyEmma Svennberg, Johan Engdahl, Faris Al-Khalili, et al.
Lancet (London, England)|September 1, 2021
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trialEmma Svennberg, Leif Friberg, Viveka Frykman, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
European Heart Journal|July 19, 2006
Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)Leif Friberg, Niklas Hammar, Mattias Ringh, et al.
BMJ (Clinical Research Ed.)|June 2, 2012
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort studyLeif Friberg, Lina Benson, Mårten Rosenqvist, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 19, 2022
Prognostic implication of premature ventricular contractions in patients without structural heart diseaseRaffaele Scorza, Martin Jonsson, Leif Friberg, et al.
Clinical Cardiology|September 7, 2019
Risk of ischemic stroke and utility of CHA<sub>2</sub> DS<sub>2</sub> -VASc score in women and men with atrial fibrillationMaria Tomasdottir, Leif Friberg, Ziad Hijazi, et al.
European Journal of Preventive Cardiology|May 17, 2022
Prognostic impact of type 1 and type 2 diabetes mellitus in atrial fibrillation and the effect of severe hypoglycaemia: a nationwide cohort studyStelios Karayiannides, Anna Norhammar, Lena Landstedt-Hallin, et al.
JAMA|November 17, 2014
Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fractionLars H Lund, Lina Benson, Ulf Dahlström, et al.
Heart (British Cardiac Society)|January 27, 2018
Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failureGianluigi Savarese, Ulrik Sartipy, Leif Friberg, et al.
Stroke|July 19, 2014
High prevalence of atrial fibrillation among patients with ischemic strokeLeif Friberg, Mårten Rosenqvist, Arne Lindgren, et al.
Circulation|April 26, 2015
Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP StudyEmma Svennberg, Johan Engdahl, Faris Al-Khalili, et al.
Lancet (London, England)|September 1, 2021
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trialEmma Svennberg, Leif Friberg, Viveka Frykman, et al.
Pageof 8